Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Controlled Contamination Services Awarded ISO 9001:2015 Certification

For over 25 years, CCS has provided facility cleaning solutions, technical services and decontamination service to millions of square feet of sensitive client spaces throughout the United States. CCS tailors its solutions with proven best practices in facility services and cleaning controlled environments. To do so, we develop the optimal cleaning strategy for each situation by assembling the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

For over 25 years, CCS has provided facility cleaning solutions, technical services and decontamination service to millions of square feet of sensitive client spaces throughout the United States. CCS tailors its solutions with proven best practices in facility services and cleaning controlled environments. To do so, we develop the optimal cleaning strategy for each situation by assembling the right resources, processes, and expert personnel to ensure the integrity of your environments.

Our Commitment to Providing the Highest Quality Services

Controlled Contamination Services’ certification to the 9001 Standard demonstrates our commitment to providing the highest quality services to our clients. As a US-based provider of enterprise solutions for the pharmaceutical, biotech, medical device, High Tech, IT, and Aerospace and Defense industries, CCS provides its clients with comprehensive cleaning, bio-decontamination, and technical service solutions that exceed the health, safety and environmental requirements of its customers.

Meeting the International Standard for a Quality Management System

The ISO 9001 standard is the international standard that specifies requirements for a quality management system (QMS). Organizations use the standard to demonstrate the ability to consistently provide products and services that meet customer and regulatory requirements. It is the ultimate global benchmark for quality management—a critical tool for both CCS and the partnerships it creates with its customers.

Continuous improvement and High-Quality Service Delivery are fundamental values at CCS. CCS’ clients require detailed and accurate documentation as well as adherence to Good Manufacturing Practices and Good Documentation Practices. CCS works under some of the most rigorous procedures as specified by the FDA and other US regulatory agencies and has a long history of developing and improving procedures and processes as well as developing and maintaining these requirements for their clients.

Streamlining Efficiency to Contain Cost and Reduce Clients’ Total Spend

The ISO certification also provides CCS the opportunity to streamline efficiency, contain cost and total spend to its clients. In addition, it allows CCS the ability to continuously improve its consistency and information flow, time management, service delivery and service performance, customer service, accountability and tracking of key performance measurements, to the highest level possible.

CCS is the leading provider of integrated facility services for the Life Sciences, High Tech, IT, and Aerospace and Defense industries. One of our highest values as a company is quality and rigorous dedication to the needs of each of our unique clients. To learn more, please visit cleanroomcleaning.com.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz brings 23+ years of experience as chief medical physicist at Texas Oncology and personal insight as a breast cancer survivor, enabling her to guide patient support groups and advocate for accessible cancer care. She emphasizes AI's potential in auto-contouring and treatment planning while stressing the need for proper training, validation, and transparency before implementation.

  • 01Over 23 years at Texas Oncology integrating personal cancer survivor experience with clinical expertise to improve patient empathy and support group leadership
  • 02AI in oncology requires human oversight, validation, and transparency; auto-contouring and auto-planning must be combined with staff training and rigorous protocol testing before deployment
  • 03Texas Oncology prioritizes offering state-of-the-art cancer treatments closer to home, including for rural patients, to reduce travel and ensure consistent, personalized care

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512